Vistin Pharma ASA: Mandatory notification of trade

Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares, corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated with board member Øystein Stray Spetalen. Attachment 20230530_Notification of trade_Ferncliff i Vistin
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share.

After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares, corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated with board member Øystein Stray Spetalen.


Attachment

  • 20230530_Notification of trade_Ferncliff i Vistin

Per maggiori informazioni

Ufficio Stampa

 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti

Allegati
Slide ShowSlide Show
Non disponibili
;